Risk of infections in bispecific antibody therapy for multiple myeloma: a comprehensive review of literature
Multiple Myeloma (MM) is a malignancy characterized by abnormal production of monoclonal immunoglobulins in plasma cells. Bispecific antibodies have emerged as a significant advancement in MM treatment, offering high effectiveness and specificity by targeting different antigens such as BCMA, CD38, a...
Na minha lista:
| Principais autores: | , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Taylor & Francis Group
2025-12-01
|
| Serier: | Hematology |
| Fag: | |
| Online adgang: | https://www.tandfonline.com/doi/10.1080/16078454.2024.2448898 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|